These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23868480)

  • 1. Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program.
    Subramanian S; Tangka FK; Hoover S; Beebe MC; DeGroff A; Royalty J; Seeff LC
    Cancer; 2013 Aug; 119 Suppl 15(Suppl 15):2855-62. PubMed ID: 23868480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.
    Tangka FK; Subramanian S; Beebe MC; Hoover S; Royalty J; Seeff LC
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2863-9. PubMed ID: 23868481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs.
    Subramanian S; Tangka FK; Hoover S; Degroff A; Royalty J; Seeff LC
    Eval Program Plann; 2011 May; 34(2):147-53. PubMed ID: 21036399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental milestones across the programmatic life cycle: implementing the CDC's Colorectal Cancer Screening Demonstration Program.
    Glover-Kudon R; DeGroff A; Rohan EA; Preissle J; Boehm JE
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2926-39. PubMed ID: 23868487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruiting patients into the CDC's Colorectal Cancer Screening Demonstration Program: strategies and challenges across 5 sites.
    Boehm JE; Rohan EA; Preissle J; DeGroff A; Glover-Kudon R
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2914-25. PubMed ID: 23868486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
    Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.
    Seeff LC; DeGroff A; Joseph DA; Royalty J; Tangka FK; Nadel MR; Plescia M
    Cancer; 2013 Aug; 119 Suppl 15():2940-6. PubMed ID: 23868488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs.
    Tangka FK; Subramanian S; Bapat B; Seeff LC; DeGroff A; Gardner J; Ryerson AB; Nadel M; Royalty J
    Prev Chronic Dis; 2008 Apr; 5(2):A47. PubMed ID: 18341782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.
    Subramanian S; Tangka FKL; Hoover S; Royalty J; DeGroff A; Joseph D
    Eval Program Plann; 2017 Jun; 62():73-80. PubMed ID: 28190597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Rohan EA
    Cancer; 2013 Aug; 119 Suppl 15():2817-9. PubMed ID: 23868475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Program Resources Required for Colonoscopy and Fecal Screening: Findings From 5 Years of the Colorectal Cancer Control Program.
    Subramanian S; Tangka FKL; Hoover S; Cole-Beebe M; Joseph D; DeGroff A
    Prev Chronic Dis; 2019 Apr; 16():E50. PubMed ID: 31022371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing the CDC's Colorectal Cancer Screening Demonstration Program: wisdom from the field.
    Rohan EA; Boehm JE; DeGroff A; Glover-Kudon R; Preissle J
    Cancer; 2013 Aug; 119 Suppl 15(Suppl 15):2870-83. PubMed ID: 23868482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborating across multiple health care institutions in an urban colorectal cancer screening program.
    Villanueva R; Gugel D; Dwyer DM
    Cancer; 2013 Aug; 119 Suppl 15():2905-13. PubMed ID: 23868485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expenditures on Screening Promotion Activities in CDC's Colorectal Cancer Control Program, 2009-2014.
    Tangka FKL; Subramanian S; Hoover S; Cole-Beebe M; DeGroff A; Joseph D; Chattopadhyay S
    Prev Chronic Dis; 2019 Jun; 16():E72. PubMed ID: 31172915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis.
    Castro G; Azrak MF; Seeff LC; Royalty J
    Cancer; 2013 Aug; 119 Suppl 15():2849-54. PubMed ID: 23868479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.
    Nadel MR; Royalty J; Shapiro JA; Joseph D; Seeff LC; Lane DS; Dwyer DM
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2834-41. PubMed ID: 23868477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of promoting cancer screening: Evidence from CDC's Colorectal Cancer Control Program (CRCCP).
    Tangka FKL; Subramanian S; Hoover S; Royalty J; Joseph K; DeGroff A; Joseph D; Chattopadhyay S
    Eval Program Plann; 2017 Jun; 62():67-72. PubMed ID: 27989647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and benefits of an organized fecal immunochemical test-based colorectal cancer screening program in the United States.
    Guy GP; Richardson LC; Pignone MP; Plescia M
    Cancer; 2014 Aug; 120(15):2308-15. PubMed ID: 24737634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a federally funded demonstration colorectal cancer screening program.
    Seeff LC; DeGroff A; Tangka F; Wanliss E; Major A; Nadel M; Ryerson AB; Royalty J; Gelb C; Reed E
    Prev Chronic Dis; 2008 Apr; 5(2):A64. PubMed ID: 18341799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of an Implementation Economics Analysis in Providing the Evidence Base for Increasing Colorectal Cancer Screening.
    Subramanian S; Tangka FKL; Hoover S
    Prev Chronic Dis; 2020 Jun; 17():E46. PubMed ID: 32584756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.